Literature DB >> 11743705

A comparison of the SF-36 and Nottingham Health Profile in patients with chronic neuropathic pain.

K Meyer-Rosberg1, C S Burckhardt, K Huizar, A Kvarnström, L O Nordfors, A Kristofferson.   

Abstract

The aim of this study was to evaluate and compare the psychometric properties of two generic health-related quality of life (HRQoL) instruments, the Short Form Health Survey (SF-36) and the Nottingham Health Profile (NHP) in a group of patients with chronic peripheral neuropathic pain (PNP). The sample consisted of 126 adults (56 men and 70 women) with PNP following a lesion of a peripheral nerve, spinal nerve or nerve root or patients with post-herpetic neuralgia. The battery of tests included visual analogue scales (VASs) for pain assessment and global rating of health and verbal rating scales of pain and other symptoms, as well as patient descriptors. The SF-36 had higher internal consistency reliability coefficients (alpha=0.79, range 0.70-0.90) than the NHP (alpha=0.68, range 0.49-0.79). Correlations between comparable dimensions of the two instruments were significant (range from -0.79 for the physical and mental dimensions to -0.29 for the social dimension) indicating a moderate degree of convergent validity. The study population had significantly worse scores on all dimensions of the two instruments when compared with the general population. Subjects with high VAS scores for pain on movement and those with low global health ratings had poorer scores on the both instruments. Overall, the SF-36 performed somewhat better on psychometric testing than did the NHP. However, the NHP contains dimensions such as sleep and more pain items which might be of particular importance in the PNP population. Since the instruments are short, both could be retained for continued testing in outcome studies of this population. Copyright 2001 European Federation of Chapters of the International Association for the Study of Pain.

Entities:  

Mesh:

Year:  2001        PMID: 11743705     DOI: 10.1053/eujp.2001.0260

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  22 in total

1.  Chronic pain patients' treatment preferences: a discrete-choice experiment.

Authors:  Axel C Mühlbacher; Uwe Junker; Christin Juhnke; Edgar Stemmler; Thomas Kohlmann; Friedhelm Leverkus; Matthias Nübling
Journal:  Eur J Health Econ       Date:  2014-06-21

2.  Chronic Constriction Injury of the Rat's Infraorbital Nerve (IoN-CCI) to Study Trigeminal Neuropathic Pain.

Authors:  Kristof Deseure; Guy H Hans
Journal:  J Vis Exp       Date:  2015-09-21       Impact factor: 1.355

3.  Neuropathic pain's biopsychosocial effects.

Authors:  Esra Dogru Huzmeli; Ismet Melek
Journal:  Neurol Sci       Date:  2017-08-19       Impact factor: 3.307

4.  Which instrument is more suitable to assess health-related quality of life: Nottingham Health Profile or Short-Form-36?

Authors:  Reinhold Jagsch; Katharina Pils
Journal:  Wien Med Wochenschr       Date:  2006-03

5.  Neuropathic pain in patients with upper-extremity nerve injury.

Authors:  Christine B Novak; Joel Katz
Journal:  Physiother Can       Date:  2010-07-23       Impact factor: 1.037

6.  Early experience with a brief, multimodal, multidisciplinary treatment program for fibromyalgia.

Authors:  Ann Vincent; Mary O Whipple; Terry H Oh; Janet A Guderian; Debra L Barton; Connie A Luedtke
Journal:  Pain Manag Nurs       Date:  2011-07-02       Impact factor: 1.929

7.  Does Neuropathic Pain Affect the Quality of Sleep?

Authors:  Meltem Alkan Melikoglu; Ahmet Celik
Journal:  Eurasian J Med       Date:  2017-02

8.  Analgesic Effects of Vilazodone, Indatraline, and Talsupram in a Rat Model of Neuropathic Pain.

Authors:  Levent Hacısüleyman; Bülent Saraç; Ziad Joha
Journal:  Turk J Pharm Sci       Date:  2022-06-27

9.  Differential regulation of glucocorticoid receptor expression in distinct columns of periaqueductal grey in rats with behavioural disability following nerve injury.

Authors:  David Mor; Kevin A Keay
Journal:  Cell Mol Neurobiol       Date:  2013-07-12       Impact factor: 5.046

10.  An open-label, non-randomized comparison of venlafaxine and gabapentin as monotherapy or adjuvant therapy in the management of neuropathic pain in patients with peripheral neuropathy.

Authors:  William Eardley; Cory Toth
Journal:  J Pain Res       Date:  2010-04-01       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.